HOWLAND CAPITAL MANAGEMENT LLC

Position in AXSM — Axsome Therapeutics, Inc.

CIK 1079112 BOSTON, MA

Position in AXSM

as of Jun 30, 2026 · filed Jul 13, 2026 Compact

Position Value

$543,389

+$168,165 QoQ

Shares Held

2,220

0.0% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#316

of 500 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HOWLAND CAPITAL MANAGEMENT LLC holds $26,069,769 across 4 Biotechnology names. AXSM ranks #4 (2.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	37,174	$23,179,475
2	ALNY	Alnylam Pharmaceuticals, Inc.	4,534	$1,364,870
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,977	$982,035
4	AXSM	Axsome Therapeutics, Inc. This page	2,220	$543,389

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$543,389	2,220	0.0%	Shares	Sole	2026-07-13
2026-03-31	$375,224	2,220	0.0%	Shares	Sole	2026-04-14
2025-12-31	$405,460	2,220	—	Shares	Sole	2026-02-13
No filing history on record for this holder in this stock.